Parvovirus B19 does not bind to membrane-associated globoside in vitro

Virology

Volumn 332, Issue 1, 2005, Pages 189-198

  Kaufmann, Bärbel ^a,b,c   Baxa, Ulrich ^b   Chipman, Paul R ^a   Rossmann, Michael G ^a   Modrow, Susanne ^c   Seckler, Robert ^b,c  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF POTSDAM   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Electron microscopy; Globoside; Hemagglutination; ITC; Liposomes; Parvoviridae; Parvovirus B19; Receptor binding; SPR

Indexed keywords

CELL SURFACE RECEPTOR; GLOBOSIDE; GLOBOTETRAOSYLCERAMIDE; PROTEIN VP2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; REGULATORY MECHANISM; VIROGENESIS;

ANIMALS; BACULOVIRIDAE; CELLS, CULTURED; GLOBOSIDES; GLYCOSPHINGOLIPIDS; HUMANS; PARVOVIRUS B19, HUMAN; RECEPTORS, VIRUS;

PARVOVIRIDAE; PARVOVIRUS;

EID: 12344292308     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.11.037     Document Type: Article

References (45)

1. M. Agbandje, S. Kajigaya, R. McKenna, N.S. Young, and M.G. Rossmann The structure of human parvovirus B19 at 8 Å resolution Virology 203 1994 106 115
2. M.J. Anderson, S.E. Jones, S.P. Fisher-Hoch, E. Lewis, S.M. Hall, C.L.R. Bartlett, B.J. Cohen, P.P. Mortimer, and M.S. Pereira Human parvovirus, the cause of erythema infectiosums (fifth disease)? Lancet 1 1983 1378
3. S. Arab, and C.A. Lingwood Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes Glycoconjugate J. 13 1996 159 166
4. P. Bailly, and J.F. Bouhours P blood group and related antigens J.P. Cartron P. Rouger Molecular Basis of Major Human Blood Group Antigens 1995 Plenum Press New York 299 329
5. D.P. Barbis, S.-F. Chang, and C.R. Parrish Mutations adjacent to the dimple of the canine parvovirus capsid structure affect sialic acid binding Virology 191 1992 301 308
6. U. Baxa, A. Cooper, A. Weintraub, W. Pfeil, and R. Seckler Enthalpic barriers to the hydrophobic binding of oligosaccharides to phage P22 tailspike protein Biochemistry 40 2001 5144 5150
7. K.E. Brown Haematological consequences of parvovirus B19 infection Bailliere's Best. Pract. Res., Clin. Haematol. 13 2000 245 259
8. K.E. Brown, J. Mori, B.J. Cohen, and A.M. Field In vitro propagation of parvovirus B19 in primary foetal liver culture J. Gen. Virol. 72 1991 741 745
9. K.E. Brown, S.M. Anderson, and N.S. Young Erythrocyte P antigen: cellular receptor for B19 parvovirus Science 262 1993 114 117
10. K.E. Brown, J.R. Hibbs, G. Gallinella, S.M. Anderson, E.D. Lehman, P. McCarthy, and N.S. Young Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen) N. Engl. J. Med. 330 1994 1192 1196
11. P.R. Chipman, M. Agbandje-McKenna, S. Kajigaya, K.E. Brown, N.S. Young, T.S. Baker, and M.G. Rossmann Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor Proc. Natl. Acad. Sci. U.S.A. 93 1996 7502 7506
12. L.L. Cooling, T.A. Koerner, and S.J. Naides Multiple glycosphingolipids determine the tissue tropism of parvovirus B19 J. Infect. Dis. 172 1995 1198 1205
13. M.A. Cooper, A. Hansson, S. Lofas, and D.H. Williams A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors Anal. Biochem. 277 2000 196 205
14. Y.E. Cossart, A.M. Field, B. Cant, and D. Widdows Parvovirus-like particles in human sera Lancet 1 1975 72 73
15. S.F. Cotmore, V.C. McKie, L.J. Anderson, C.R. Astell, and P. Tattersall Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments J. Virol. 60 1986 548 557
16. E.M. Erb, X. Chen, S. Allen, C.J. Roberts, S.J. Tendler, M.C. Davies, and S. Forsen Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip Anal. Biochem. 280 2000 29 35
17. J.M. Fox, and M.E. Bloom Identification of a cell surface protein from Crandell feline kidney cells that specifically binds Aleutian mink disease parvovirus J. Virol. 73 1999 3835 3842
18. S.D. Fuller, S.J. Butcher, R.H. Cheng, and T.S. Baker Three-dimensional reconstruction of icosahedral particles-the uncommon line J. Struct. Biol. 116 1996 48 55
19. A. Gigler, S. Dorsch, A. Hemauer, C. Williams, S. Kim, N.S. Young, S. Zolla-Pazner, H. Wolf, M.K. Gorny, and S. Modrow Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins J. Virol. 73 1999 1974 1979
20. G.L. Gilbert Parvovirus B19 infection and its significance in pregnancy Commun. Dis. Intell. 24 2000 69 71
21. A.M. Haywood Virus receptors: binding, adhesion strengthening, and changes in viral structure J. Virol. 68 1994 1 5
22. A.J. Humphrey, C. Fremann, P. Critchley, Y. Malykh, R. Schauer, and T.D. Bugg Biological properties of N-acyl and N-haloacetyl neuraminic acids: processing by enzymes of sialic acid metabolism, and interaction with influenza virus Bioorg. Med. Chem. 10 2002 3175 3185
23. D.H. Jones, C.A. Lingwood, K.R. Barber, and C.W. Grant Globoside as a membrane receptor: a consideration of oligosaccharide communication with the hydrophobic domain Biochemistry 36 1997 8539 8547
24. S. Kajigaya, H. Fujii, A. Field, S. Anderson, S. Rosenfeld, L.J. Anderson, T. Shimada, and N.S. Young Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions Proc. Natl. Acad. Sci. U.S.A. 88 1991 4646 4650
25. R. Kannagi, S.B. Levery, F. Ishigami, S. Hakomori, L.H. Shevinsky, B.B. Knowles, and D. Solter New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3 J. Biol. Chem. 258 1983 8934 8942
26. V.L. Katz, N.C. Chescheir, and M. Bethea Hydrops fetalis from B19 parvovirus infection J. Perinatol. 10 1990 366 368
27. B. Kaufmann, A.A. Simpson, and M.G. Rossmann The structure of human parvovirus B19 Proc. Natl. Acad. Sci. U.S.A. 101 2004 11628 11633
28. Y.C. Lee, and R.T. Lee Carbohydrate-protein interactions: basis of glycobiology Acc. Chem. Res. 28 1995 322 327
29. R. Liang, J. Loebach, N. Horan, M. Ge, C. Thompson, L. Yan, and D. Kahne Polyvalent binding to carbohydrates immobilized on an insoluble resin Proc. Natl. Acad. Sci. U.S.A. 94 1997 10554 10559
30. M. Mammen, S.-K. Choi, and G.M. Whitesides Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. 37 1998 2755 2794
31. N.C. Munshi, S. Zhou, M.J. Woody, D.A. Morgan, and A. Srivastava Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02 J. Virol. 67 1993 562 566
32. S.J. Naides Infection with parvovirus B19 Curr. Infect. Dis. Rep. 1 1999 273 278
33. H. Nakajima, N. Kiyokawa, Y.U. Katagiri, T. Taguchi, T. Suzuki, T. Sekino, K. Mimori, T. Ebata, M. Saito, H. Nakao, T. Takeda, and J. Fujimoto Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance J. Biol. Chem. 276 2001 42915 42922
34. L.C. Norkin Virus receptors: implications for pathogenesis and the design of antiviral agents Clin. Microbiol. Rev. 8 1995 293 315
35. T. Orth, W. Herr, T. Spahn, T. Voigtlander, D. Michel, T. Mertens, W.J. Mayet, W. Dippold, and K.H. Meyer zum Büschenfelde Human parvovirus B19 infection associated with severe acute perimyocarditis in a 34-year-old man Eur. Heart J. 18 1997 524 525
36. K. Ozawa, and N. Young Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures J. Virol. 61 1987 2627 2630
37. K. Ozawa, G. Kurtzman, and N. Young Replication of the B19 parvovirus in human bone marrow cell cultures Science 233 1986 883 886
38. K. Ozawa, J. Ayub, and N. Young Translational regulation of B19 parvovirus capsid protein production by multiple upstream AUG triplets J. Biol. Chem. 263 1988 10922 10926
39. C.R. Parrish, G. Burtonboy, and L.E. Carmichael Characterization of a nonhemagglutinating mutant of canine parvovirus Virology 163 1988 230 232
40. S. Ponnazhagan, K.A. Weigel, S.P. Raikwar, P. Mukherjee, M.C. Yoder, and A. Srivastava Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes J. Virol. 72 1998 5224 5230
41. S. Serke, T.F. Schwarz, H. Baurmann, A. Kirsch, B. Hottentrager, A. von-Brunn, M. Roggendorf, D. Huhn, and F. Deinhardt Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization Br. J. Haematol. 79 1991 6 13
42. S. Terrettaz, T. Stora, C. Duschl, and H. Vogel Protein binding to supported lipid membranes: investigation of the cholera toxin-ganglioside interaction by simultaneous impedance spectroscopy and surface plasmon resonance Langmuir 9 1993 1361 1369
43. K.A. Weigel-Kelley, M.C. Yoder, and A. Srivastava Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells J. Virol. 75 2001 4110 4116
44. K.A. Weigel-Kelley, M.C. Yoder, and A. Srivastava α5β1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of β1 integrin for viral entry Blood 102 2003 3927 3933
45. N. Yaegashi, H. Shiraishi, T. Takeshita, M. Nakamura, A. Yajima, and K. Sugamura Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver J. Virol. 63 1989 2422 2426